The global liquid biopsy market is experiencing substantial growth, driven by increasing demand for non-invasive diagnostic technologies that detect molecular biomarkers using liquid samples, thus ...
Water damage remains one of the most costly and disruptive problems in both residential and commercial spaces. Often triggered by unnoticed leaks from appliances, HVAC systems, or plumbing, it can ...
Four oral sessions to be presented, including validation data for Shield MCD test, selected for highly anticipated NCI Vanguard Study 18 total abstracts to showcase significant developments in ...
CAMBRIDGE, England, January 20, 2026--biomodal, an omics-based life sciences technology and analytics company, today announced the publication of a study in Nature Communications Medicine showcasing ...
MCED is able to detect multiple cancer types by analyzing cfDNAs, cfRNAs, circulating proteins and metabolites using liquid-based biopsy techniques and AI algorithms. The TOO results of an MCED test ...
(a) Deep learning-based circulating exosome analysis for lung cancer detection (copyright American Chemical Society, 2024); (b) The operational mechanism of the Förster resonance energy transfer (FRET ...
Post-progression therapies and outcomes for patients with advanced, BRCA-related pancreatic cancer after receipt of PARP inhibitors: A national retrospective cohort study. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results